Insufficient scRNA-seq data for expression of RXFP4 at single-cell level.
Insufficient scRNA-seq data for expression of RXFP4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 81% | 59.67 | 779 / 966 | 77% | 5.08 | 405 / 527 |
| stomach | 53% | 2.37 | 191 / 359 | 57% | 3.53 | 164 / 286 |
| pancreas | 60% | 2.69 | 198 / 328 | 49% | 1.35 | 88 / 178 |
| bladder | 67% | 7.38 | 14 / 21 | 26% | 1.52 | 129 / 504 |
| kidney | 80% | 5.63 | 71 / 89 | 3% | 0.63 | 27 / 901 |
| lung | 70% | 5.42 | 406 / 578 | 8% | 0.19 | 93 / 1155 |
| spleen | 76% | 5.35 | 182 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 54% | 2.52 | 780 / 1445 | 19% | 0.50 | 35 / 183 |
| breast | 69% | 3.81 | 317 / 459 | 2% | 0.05 | 25 / 1118 |
| adipose | 67% | 4.32 | 806 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 63% | 3.79 | 842 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 54% | 3.18 | 91 / 170 | 7% | 0.25 | 34 / 459 |
| peripheral blood | 59% | 3.34 | 544 / 929 | 0% | 0 | 0 / 0 |
| thymus | 56% | 2.34 | 363 / 653 | 2% | 0.08 | 12 / 605 |
| ovary | 39% | 1.82 | 70 / 180 | 16% | 0.35 | 69 / 430 |
| brain | 48% | 3.42 | 1281 / 2642 | 2% | 0.08 | 11 / 705 |
| prostate | 44% | 1.64 | 108 / 245 | 2% | 0.04 | 10 / 502 |
| skin | 40% | 1.46 | 731 / 1809 | 1% | 0.01 | 3 / 472 |
| heart | 36% | 1.22 | 311 / 861 | 0% | 0 | 0 / 0 |
| muscle | 34% | 1.22 | 270 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 31% | 1.05 | 81 / 258 | 0% | 0.01 | 1 / 230 |
| liver | 16% | 0.47 | 37 / 226 | 4% | 0.10 | 16 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_2000253 | Biological process | positive regulation of feeding behavior |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RXFP4 |
| Protein name | Relaxin-3 receptor 2 (RLN3 receptor 2) (G-protein coupled receptor 100) (G-protein coupled receptor GPCR142) (Insulin-like peptide INSL5 receptor) (Relaxin family peptide receptor 4) |
| Synonyms | GPR100 GPCR142 RLN3R2 |
| Description | FUNCTION: High affinity receptor for INSL5. Also acts as a receptor for RLN3/relaxin-3, as well as bradykinin and kallidin. Binding of the ligand inhibit cAMP accumulation. . |
| Accessions | Q8TDU9 ENST00000368318.5 |